A detailed history of First Trust Advisors LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Trust Advisors LP holds 1,110,501 shares of BMY stock, worth $63.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,110,501
Previous 2,712,045 59.05%
Holding current value
$63.1 Million
Previous $113 Million 48.98%
% of portfolio
0.06%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $63.5 Million - $82.9 Million
-1,601,544 Reduced 59.05%
1,110,501 $57.5 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $12.8 Million - $16.9 Million
318,349 Added 13.3%
2,712,045 $113 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $139 Million - $158 Million
-2,907,449 Reduced 54.85%
2,393,696 $130 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $49 Million - $58.5 Million
1,011,551 Added 23.58%
5,301,145 $272 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $16.2 Million - $18.1 Million
279,830 Added 6.98%
4,289,594 $249 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $6.12 Million - $6.8 Million
96,133 Added 2.46%
4,009,764 $256 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $12.2 Million - $13.8 Million
185,824 Added 4.98%
3,913,631 $271 Million
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $23.2 Million - $27.5 Million
339,358 Added 10.02%
3,727,807 $268 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $47,934 - $28.3 Million
-368,730 Reduced 9.81%
3,388,449 $241 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $203 Million - $223 Million
2,789,796 Added 288.39%
3,757,179 $289 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $13.3 Million - $15.9 Million
-215,634 Reduced 18.23%
967,383 $70.6 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $303,438 - $353,738
5,658 Added 0.48%
1,183,017 $73.8 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $3.95 Million - $4.62 Million
-66,715 Reduced 5.36%
1,177,359 $69.7 Million
Q2 2021

Oct 12, 2021

SELL
$61.91 - $67.42 $6.19 Million - $6.74 Million
-100,000 Reduced 7.44%
1,244,074 $83.1 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $13.1 Million - $14.2 Million
210,973 Added 18.62%
1,344,074 $89.8 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $2.71 Million - $3.05 Million
-45,747 Reduced 3.88%
1,133,101 $71.6 Million
Q4 2020

Feb 02, 2021

SELL
$57.74 - $65.43 $2.42 Million - $2.74 Million
-41,901 Reduced 3.43%
1,178,848 $73.1 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $6.68 Million - $7.4 Million
-116,256 Reduced 8.7%
1,220,749 $73.6 Million
Q2 2020

Jul 22, 2020

SELL
$54.82 - $64.09 $113 Million - $132 Million
-2,065,754 Reduced 60.71%
1,337,005 $78.6 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $42.9 Million - $62.3 Million
923,686 Added 37.26%
3,402,759 $190 Million
Q4 2019

Feb 03, 2020

BUY
$49.21 - $64.19 $24.6 Million - $32.1 Million
500,624 Added 25.3%
2,479,073 $159 Million
Q3 2019

Nov 04, 2019

BUY
$42.77 - $50.71 $14.4 Million - $17 Million
335,667 Added 20.43%
1,978,449 $100 Million
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $31.8 Million - $35.2 Million
712,809 Added 76.65%
1,642,782 $74.5 Million
Q1 2019

May 09, 2019

BUY
$45.12 - $53.8 $20 Million - $23.9 Million
443,962 Added 91.35%
929,973 $44.4 Million
Q4 2018

Feb 07, 2019

BUY
$48.76 - $63.23 $1.87 Million - $2.43 Million
38,386 Added 8.58%
486,011 $25.3 Million
Q3 2018

Oct 25, 2018

SELL
$55.19 - $62.25 $4.8 Million - $5.42 Million
-87,004 Reduced 16.27%
447,625 $27.8 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $1.79 Million - $2.23 Million
-35,357 Reduced 6.2%
534,629 $29.6 Million
Q1 2018

Apr 23, 2018

SELL
$59.92 - $68.98 $22.4 Million - $25.8 Million
-373,740 Reduced 39.6%
569,986 $36.1 Million
Q4 2017

Feb 08, 2018

BUY
$59.94 - $65.35 $24.9 Million - $27.1 Million
415,275 Added 78.58%
943,726 $57.8 Million
Q3 2017

Oct 24, 2017

BUY
$55.23 - $63.74 $29.2 Million - $33.7 Million
528,451
528,451 $33.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.